Gold nanoparticle-based platforms for vaccine development.
Drug Discov Today Technol
; 38: 57-67, 2020 Dec.
Article
em En
| MEDLINE
| ID: mdl-34895641
ABSTRACT
Since their discovery, therapeutic or prophylactic vaccines represent a promising option to prevent or cure infections and other pathologies, such as cancer or autoimmune disorders. More recently, among a number of nanomaterials, gold nanoparticles (AuNPs) have emerged as novel tools for vaccine developments, thanks to their inherent ability to tune and upregulate immune response. Moreover, owing to their features, AuNPs can exert optimal actions both as delivery systems and as adjuvants. Notwithstanding the potential huge impact in vaccinology, some challenges remain before AuNPs in vaccine formulations can be translated into the clinic. The current review provides an updated overview of the most recent and effective application of gold nanoparticles as efficient means to develop a new generation of vaccine.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas
/
Nanopartículas Metálicas
Idioma:
En
Revista:
Drug Discov Today Technol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Itália